NMS


Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.

NMS

National Market System

A trading system listing securities that trade in both New York and on regional exchanges. This allows investors to find the best price available for securities. The NMS also facilitates trading of certain over-the-counter stocks. It is sponsored and managed by NASDAQ and FINRA. See also: 19c-3 stock.

Normal Market Size

The number of shares in a publicly-traded company that can be traded at a given price. The normal market size is a set number determined by the stock's market capitalization. Market makers must trade within the parameters of the normal market size. If a market maker wants to buy or sell more shares than the normal market size, he/she must negotiate a new price. The normal market size exists to keep particularly large orders from affecting the share price, thus reducing volatility.

NMS

National Market System (NMS).

The National Market System (NMS) links all the major stock markets in the United States and was developed to foster competition among them.

Federal rules require these trading centers to ensure that transactions are executed at prices at least as good as protected quotations displayed at another center. A protected quotation is one that's immediately and automatically accessible.

References in periodicals archive ?
NMS Capital Group is a private equity, merchant banking and advisory firm with investments in businesses across multiple asset classes ranging from real estate, financial services, technology, media, and consumer products manufacturing.
A month after the Court of Appeals ruling, a federal judge allowed a lawsuit filed by NMS alleging state officials targeted its nursing homes with enforcement procedures to move forward.
We are extremely proud to be delivering Crystal Control NMS to help STN maintain that quality at all times and ensure operators are alerted to any potential anomalies before they become a problem."
With respect to VAS score, the median (IQR) VAS scores were 1 (0-2), 1 (0-2), 2 (1-3), and 3 (1-5) points, respectively, in the MCS, MMSS, MSSS, and NMS groups ( H = 27.80, P < 0.001).
Neuroleptic malignant syndrome (NMS) is a life threatening idiosyncratic reaction caused by an adverse reaction to medications with dopamine receptor - antagonist properties or the rapid withdrawal of dopaminergic medications and is characterized by fever, altered mental status, muscle rigidity and autonomic dysfunction.
There, however, would seem to be little evolutionary advantage for the passive association of NMS with neurodegenerative diseases in aging.
This case illustrates many of the complexities involved in diagnosis and management of NMS. Diagnostically, NMS can be challenging to recognize without a high index of clinical suspicion.
"The NMS Group is highly aligned with our existing strategy in oncology, and we are extremely excited about the opportunity to integrate the existing top-class level of the research into our universal platform.
With the creation of this Global Solutions Team, NMS will attend various conferences like the upcoming Affiliate World Asia to be held in Bangkok, Thailand on December 6-7 of this year.
Neuroleptic malignant syntrome (NMS) was first reported by Delay and coworkers in 1960 following the introduction of neuroleptic drugs.
Nonmarket strategy (NMS) refers to any part of a firm's strategy that seeks to generate superior performance through means not directly associated with market activity, such as lobbying legislators, colluding with rivals to erect industry entry barriers, and pursuing direct business-government partnerships.
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs.